PUMA BIOTECHNOLOGY, INC.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
Insider trades, last 90 days
0 buys · 5 sells
- Sold $1.12M
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
160
- +3 vs. Q1 2026
- Total value $313.59M
Superinvestors holding PBYI
0
- None of the superinvestors held PBYI at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by PBYI insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 20269:13 PM ET | Sep 14, 2026 | WILSON TROY EDWARDDirector | SSaleCommon Stock | −5K | $9.10 | −$45.5K | 54.75K | −8.4% | SEC10b5-1 |
| Sep 16, 20269:06 PM ET | Sep 14, 2026 | Cesano AlessandraDirector | SSaleCommon Stock | −62.15K | $9.123 | −$566.99K | 56.7K | −52.3% | SEC10b5-1 |
| Jul 8, 20268:21 PM ET | Jul 6, 2026 | AUERBACH ALAN HPresident and CEO | SSaleCommon Stock | −44.06K | $8.263 | −$364.05K | 7.26M | −0.6% | SEC10b5-1 |
| Jul 8, 20268:19 PM ET | Jul 6, 2026 | HUNT DOUGLAS MSee Remarks | SSaleCommon Stock | −8.46K | $8.263 | −$69.9K | 196.84K | −4.1% | SEC10b5-1 |
| Jul 8, 20268:18 PM ET | Jul 6, 2026 | NOUGUES MAXIMO FChief Financial Officer | SSaleCommon Stock | −9.39K | $8.263 | −$77.56K | 230.64K | −3.9% | SEC10b5-1 |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in PBYI at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ACORN CAPITAL ADVISORS, LLC | 4,131,299 | $33.5M | 9.14% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,804,736 | $30.86M | 0.00% | +205,784+5.7% | Added |
| AMERICAN CENTURY COMPANIES INC | 2,319,996 | $18.82M | 0.01% | +403,650+21.1% | Added |
| ACADIAN ASSET MANAGEMENT LLC | 2,053,523 | $16.65M | 0.02% | +11,764+0.6% | Added |
| RENAISSANCE TECHNOLOGIES LLC | 1,836,213 | $14.89M | 0.02% | −106,200−5.5% | Reduced |